Mesoblast Limited(MESO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MESO Mesoblast Limited

盘前交易 03-03 06:05:21 EST

14.51

-1.34

-8.45%

最高14.97	最低14.37	成交量59.28万
今开14.80	昨收15.85	日振幅3.75%
总市值18.62亿	流通市值11.41亿	总股本1.28亿
成交额863.15万	换手率0.75%	流通股本7,865万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"MESO","market":"US","secType":"STK","nameCN":"Mesoblast Limited","latestPrice":14.51,"timestamp":1772485200000,"preClose":15.85,"halted":0,"volume":592760,"delay":0,"changeRate":-0.08454258675078864,"floatShares":78649063,"shares":128296718,"eps":-0.73592,"marketStatus":"盘前交易","change":-1.34,"latestTime":"03-03 06:05:21 EST","open":14.8,"high":14.965,"low":14.37,"amount":8631456.9572,"amplitude":0.037539,"askPrice":15.75,"askSize":100,"bidPrice":9.15,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.73592,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1772548200000},"marketStatusCode":1,"adr":1,"adrRate":10,"listingDate":1447390800000,"exchange":"NASDAQ","adjPreClose":14.51,"postHourTrading":{"tag":"盘后","latestPrice":14.55,"preClose":14.51,"latestTime":"19:31 EST","volume":1312,"amount":19088.77,"timestamp":1772497876691,"change":0.04,"changeRate":0.002757,"amplitude":0.007581},"volumeRatio":2.72112406326271,"impliedVol":0.594,"impliedVolPercentile":0.46},"requestUrl":"/m/hq/s/MESO","defaultTab":"news","newsList":[{"id":"1110626132","title":"Mesoblast Limited预计2026财年Ryoncil净收入将达1.1亿至1.2亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1110626132","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110626132?lang=zh_cn&edition=full","pubTime":"2026-02-27 05:53","pubTimestamp":1772142784,"startTime":"0","endTime":"0","summary":"生物技术企业Mesoblast Limited最新预测显示，其核心产品Ryoncil在2026财年的全年净收入预计将介于1.1亿美元至1.2亿美元之间。这一预期反映了公司对产品商业化前景的信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MSB.AU","BK7501","BK7508","BK7067","BK4139","MESO"],"gpt_icon":0},{"id":"2611903966","title":"Mesoblast Ltd盘中异动 早盘大幅下跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2611903966","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611903966?lang=zh_cn&edition=full","pubTime":"2026-02-12 22:37","pubTimestamp":1770907021,"startTime":"0","endTime":"0","summary":"北京时间2026年02月12日22时37分，Mesoblast Ltd股票出现波动，股价快速下跌5.05%。截至发稿，该股报17.38美元/股，成交量2.8026万股，换手率0.02%，振幅1.39%。Mesoblast Ltd股票所在的生物技术行业中，整体跌幅为0.33%。Mesoblast Ltd公司简介：Mesoblast Ltd 是一家商业化阶段的生物技术公司，在开发用于治疗严重及危及生命的炎症疾病的同种异体（现成）细胞药物方面处于全球领先地位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212223701a49ceb52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212223701a49ceb52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MESO","BK4139"],"gpt_icon":0},{"id":"2603315633","title":"Mesoblast Ltd盘中异动 早盘股价大跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603315633","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603315633?lang=zh_cn&edition=full","pubTime":"2026-01-13 22:55","pubTimestamp":1768316118,"startTime":"0","endTime":"0","summary":"北京时间2026年01月13日22时55分，Mesoblast Ltd股票出现异动，股价急速下跌5.12%。截至发稿，该股报17.72美元/股，成交量5.2827万股，换手率0.04%，振幅3.54%。Mesoblast Ltd股票所在的生物技术行业中，整体跌幅为0.08%。Mesoblast Ltd公司简介：Mesoblast Ltd 是一家商业化阶段的生物技术公司，在开发用于治疗严重及危及生命的炎症疾病的同种异体（现成）细胞药物方面处于全球领先地位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113225518a4bf5d2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113225518a4bf5d2b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MESO"],"gpt_icon":0},{"id":"1109683405","title":"Mesoblast Limited - 预计2025年12月31日季度毛收入超过3000万美元，来自Ryoncil的销售","url":"https://stock-news.laohu8.com/highlight/detail?id=1109683405","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109683405?lang=zh_cn&edition=full","pubTime":"2025-11-25 22:45","pubTimestamp":1764081909,"startTime":"0","endTime":"0","summary":"Mesoblast Limited - 预计2025年12月31日季度毛收入超过3000万美元，来自Ryoncil的销售","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK7508","BK7067","BK7501","MESO","MSB.AU"],"gpt_icon":0},{"id":"1195991725","title":"新闻稿：詹姆斯·M·奥布莱恩被任命为美莎比信托首席财务官","url":"https://stock-news.laohu8.com/highlight/detail?id=1195991725","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195991725?lang=zh_cn&edition=full","pubTime":"2025-11-17 14:56","pubTimestamp":1763362561,"startTime":"0","endTime":"0","summary":"纽约，2025年11月17日-- 美莎比信托，全球领先的用于治疗炎症性疾病的同种异体细胞药物公司，今天宣布，在公司向一个完全整合的商业组织转型之际，任命詹姆斯·M·奥布莱恩为其美国首席财务官。詹姆斯在财务管理和规划的各个方面拥有丰富经验，职业生涯的大部分时间都在生命科学、生物技术和制药行业的跨国公私公司中度过。本发布已获首席执行官授权。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MESO","MSB","CFO","BK4575","BK4139","BK4150","BK7501","BMS","BK7067","MSB.AU","R","BK4006","BK4232","MSC","BK7508","BK4022"],"gpt_icon":0},{"id":"2582332310","title":"Mesoblast Ltd盘中异动 下午盘快速上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582332310","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582332310?lang=zh_cn&edition=full","pubTime":"2025-11-11 03:56","pubTimestamp":1762804587,"startTime":"0","endTime":"0","summary":"北京时间2025年11月11日03时56分，Mesoblast Ltd股票出现波动，股价大幅拉升5.00%。截至发稿，该股报15.34美元/股，成交量10.0524万股，换手率0.08%，振幅2.16%。Mesoblast Ltd股票所在的生物技术行业中，整体涨幅为0.85%。Mesoblast Ltd公司简介：Mesoblast Ltd 是一家商业化阶段的生物技术公司，在开发用于治疗严重及危及生命的炎症疾病的同种异体（现成）细胞药物方面处于全球领先地位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111035627a497f520&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111035627a497f520&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLTO","MESO"],"gpt_icon":0},{"id":"1199521939","title":"Mesoblast将于下月与FDA会面讨论Rexlemestrocel-L和药物戒断","url":"https://stock-news.laohu8.com/highlight/detail?id=1199521939","media":"美股速递","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199521939?lang=zh_cn&edition=full","pubTime":"2025-11-05 06:59","pubTimestamp":1762297168,"startTime":"0","endTime":"0","summary":"Mesoblast将于下月与FDA会面，讨论Rexlemestrocel-L和药物戒断的相关事宜。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MSB.AU","BK7501","BK7508","BK7067","BK4139","MESO"],"gpt_icon":0},{"id":"2577238292","title":"Mesoblast Ltd盘中异动 早盘股价大涨6.64%报18.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2577238292","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577238292?lang=zh_cn&edition=full","pubTime":"2025-10-21 21:32","pubTimestamp":1761053572,"startTime":"0","endTime":"0","summary":"北京时间2025年10月21日21时32分，Mesoblast Ltd股票出现波动，股价大幅拉升6.64%。截至发稿，该股报18.82美元/股，成交量2.195万股，换手率0.02%，振幅1.70%。Mesoblast Ltd股票所在的生物技术行业中，整体跌幅为0.07%。Mesoblast Ltd公司简介：Mesoblast Ltd 是一家商业化阶段的生物技术公司，在开发用于治疗严重及危及生命的炎症疾病的同种异体（现成）细胞药物方面处于全球领先地位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251021213253a6c601fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251021213253a6c601fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MESO","BK4139"],"gpt_icon":0},{"id":"2518727136","title":"Mesoblast Ltd盘中异动 股价大跌5.09%报12.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518727136","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518727136?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:57","pubTimestamp":1741615065,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时57分，Mesoblast Ltd股票出现异动，股价急速下挫5.09%。截至发稿，该股报12.78美元/股，成交量2.7964万股，换手率0.02%，振幅3.41%。Mesoblast Ltd股票所在的生物技术行业中，整体涨幅为0.22%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Mineralys Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为2983.67%、650.72%、233.81%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Scisparc Ltd.、Impact Biomedical, Inc.，振幅分别为41.36%、40.24%、28.59%。Mesoblast Ltd公司简介：Mesoblast Ltd是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310215745abf30668&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310215745abf30668&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MESO"],"gpt_icon":0},{"id":"2517532162","title":"Mesoblast Ltd盘中异动 早盘股价大跌5.40%报14.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517532162","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517532162?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:34","pubTimestamp":1741271645,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时34分，Mesoblast Ltd股票出现波动，股价急速下挫5.40%。截至发稿，该股报14.02美元/股，成交量7999股，换手率0.01%，振幅0.20%。Mesoblast Ltd股票所在的生物技术行业中，整体跌幅为0.64%。其相关个股中，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 涨幅较大，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为982.88%、121.32%、51.43%，振幅较大的相关个股有Plus Therapeutics, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Aeon Biopharma, Inc.，振幅分别为24.20%、23.12%、21.05%。Mesoblast Ltd公司简介：Mesoblast Ltd是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223406a26290b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223406a26290b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MESO","BK4139"],"gpt_icon":0},{"id":"2516776426","title":"Mesoblast Ltd盘中异动 早盘大幅下挫7.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516776426","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516776426?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:32","pubTimestamp":1741098755,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时32分，Mesoblast Ltd股票出现异动，股价急速跳水7.28%。截至发稿，该股报14.29美元/股，成交量7.2525万股，换手率0.06%，振幅1.87%。Mesoblast Ltd股票所在的生物技术行业中，整体涨幅为0.25%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Protagenic Therapeutics, Inc.、Exicure, Inc.涨幅较大，Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为1054.09%、1048.63%、413.99%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Adma Biologics Inc、Amylyx Pharmaceuticals, Inc.，振幅分别为23.30%、12.13%、11.00%。Mesoblast Ltd公司简介：Mesoblast Ltd是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223235abe7efcc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223235abe7efcc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MESO"],"gpt_icon":0},{"id":"2516634203","title":"Mesoblast Ltd盘中异动 股价大跌6.71%报16.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516634203","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516634203?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:32","pubTimestamp":1741012346,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时32分，Mesoblast Ltd股票出现异动，股价快速下挫6.71%。截至发稿，该股报16.00美元/股，成交量3.1284万股，换手率0.02%，振幅1.74%。Mesoblast Ltd股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Entero Therapeutics Inc.、Alto Neuroscience, Inc.、Geovax Labs, Inc.涨幅较大，Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为47.27%、26.94%、22.55%，振幅较大的相关个股有Entero Therapeutics Inc.、Spruce Biosciences, Inc.、Cibus, Inc.，振幅分别为21.22%、19.25%、9.55%。Mesoblast Ltd公司简介：Mesoblast Ltd是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223226a25d4003&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223226a25d4003&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MESO"],"gpt_icon":0},{"id":"2514132003","title":"Mesoblast Ltd盘中异动 早盘股价大涨5.79%报16.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514132003","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514132003?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:31","pubTimestamp":1740753063,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时31分，Mesoblast Ltd股票出现异动，股价急速拉升5.79%。截至发稿，该股报16.44美元/股，成交量4.5267万股，换手率0.04%，振幅0.26%。Mesoblast Ltd股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Anaptysbio, Inc.、Enveric Biosciences, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Virpax Pharmaceuticals, Inc.、Enveric Biosciences, Inc.较为活跃，换手率分别为480.24%、239.11%、55.69%，振幅较大的相关个股有Trevi Therapeutics, Inc.、Enanta Pharmaceuticals, Inc.、Aardvark Therapeutics, Inc.，振幅分别为7.11%、6.58%、6.22%。Mesoblast Ltd公司简介：Mesoblast Ltd是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223104abe0e9f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223104abe0e9f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MESO","BK4139"],"gpt_icon":0},{"id":"2514015324","title":"Mesoblast Ltd盘中异动 早盘急速下挫5.30%报15.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514015324","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514015324?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:21","pubTimestamp":1740496865,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时21分，Mesoblast Ltd股票出现异动，股价大幅下挫5.30%。截至发稿，该股报15.37美元/股，成交量8.439万股，换手率0.07%，振幅4.93%。Mesoblast Ltd股票所在的生物技术行业中，整体涨幅为0.80%。其相关个股中，Abpro Holdings Inc C/Wts 12/11/2029 、Tc Biopharm  Plc C/Wts 10/02/2028 、Lava Therapeutics N.V.涨幅较大，Gt Biopharma, Inc.、Moleculin Biotech, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为1057.75%、589.47%、551.79%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Silexion Therapeutics Corp、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为63.66%、61.16%、60.87%。Mesoblast Ltd公司简介：Mesoblast Ltd是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225232105962ffdf8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225232105962ffdf8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MESO"],"gpt_icon":0},{"id":"2513211297","title":"Mesoblast Ltd盘中异动 下午盘急速下挫5.43%报16.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513211297","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513211297?lang=zh_cn&edition=full","pubTime":"2025-02-22 03:29","pubTimestamp":1740166198,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日03时29分，Mesoblast Ltd股票出现波动，股价大幅下跌5.43%。截至发稿，该股报16.30美元/股，成交量11.922万股，换手率0.09%，振幅4.29%。Mesoblast Ltd股票所在的生物技术行业中，整体涨幅为0.45%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Invivyd, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Aditxt, Inc.、Nkgen Biotech, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为306.99%、249.33%、137.15%，振幅较大的相关个股有Osr Holdings, Inc.、Invivyd, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为76.52%、70.25%、61.26%。Mesoblast Ltd公司简介：Mesoblast Ltd是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222032958962bbb5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222032958962bbb5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MESO"],"gpt_icon":0},{"id":"2510989575","title":"Mesoblast Ltd盘中异动 下午盘急速跳水5.13%报18.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510989575","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510989575?lang=zh_cn&edition=full","pubTime":"2025-02-11 02:24","pubTimestamp":1739211896,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日02时24分，Mesoblast Ltd股票出现波动，股价急速下跌5.13%。截至发稿，该股报18.49美元/股，成交量13.4905万股，换手率0.11%，振幅6.26%。Mesoblast Ltd股票所在的生物技术行业中，整体跌幅为0.23%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Biodexa Pharmaceuticals Plc、Dominari Holdings Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃，换手率分别为3054.50%、1635.23%、1328.56%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Abpro Holdings Inc C/Wts 12/11/2029 、Biodexa Pharmaceuticals Plc，振幅分别为99.86%、87.80%、87.71%。Mesoblast Ltd公司简介：Mesoblast Ltd是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211022456a240d220&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211022456a240d220&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MESO"],"gpt_icon":0},{"id":"2509442337","title":"Mesoblast Ltd盘中异动 大幅上涨6.13%报19.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509442337","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509442337?lang=zh_cn&edition=full","pubTime":"2025-02-07 22:32","pubTimestamp":1738938730,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日22时32分，Mesoblast Ltd股票出现波动，股价大幅上涨6.13%。截至发稿，该股报19.84美元/股，成交量1.1938万股，换手率0.01%，振幅0.35%。Mesoblast Ltd股票所在的生物技术行业中，整体跌幅为0.09%。其相关个股中，Conduit Pharmaceuticals Inc.、Engene Holdings Inc C/Wts 31/10/2028  Cl A、Nutriband Inc.涨幅较大，Conduit Pharmaceuticals Inc.、Lipella Pharmaceuticals Inc.、Aditxt, Inc.较为活跃，换手率分别为1062.53%、40.21%、33.54%，振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Nutriband Inc.、Renovorx, Inc.，振幅分别为30.97%、16.49%、10.27%。Mesoblast Ltd公司简介：Mesoblast Ltd是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207223210abc62aff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207223210abc62aff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MESO","BK4139"],"gpt_icon":0},{"id":"2509282618","title":"Mesoblast Ltd盘中异动 早盘股价大跌6.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509282618","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509282618?lang=zh_cn&edition=full","pubTime":"2025-02-05 22:31","pubTimestamp":1738765909,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日22时31分，Mesoblast Ltd股票出现异动，股价急速跳水6.56%。截至发稿，该股报19.06美元/股，成交量3.1482万股，换手率0.02%，振幅3.84%。Mesoblast Ltd股票所在的生物技术行业中，整体涨幅为0.80%。其相关个股中，Oragenics Inc.、Pasithea Therapeutics Corp.、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，Pasithea Therapeutics Corp.、60 Degrees Pharmaceuticals, Inc.、Oragenics Inc.较为活跃，换手率分别为2642.98%、597.64%、585.19%，振幅较大的相关个股有Pasithea Therapeutics Corp.、Eyepoint Pharmaceuticals, Inc.、Oragenics Inc.，振幅分别为16.82%、11.68%、9.75%。Mesoblast Ltd公司简介：Mesoblast Ltd是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205223149a23a7a6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205223149a23a7a6f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KTTA","MESO","BK4139"],"gpt_icon":0},{"id":"2507643539","title":"Mesoblast Ltd盘中异动 股价大涨5.12%报20.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507643539","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507643539?lang=zh_cn&edition=full","pubTime":"2025-01-31 23:44","pubTimestamp":1738338257,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日23时44分，Mesoblast Ltd股票出现异动，股价大幅上涨5.12%。截至发稿，该股报20.52美元/股，成交量7.0065万股，换手率0.06%，振幅4.02%。Mesoblast Ltd股票所在的生物技术行业中，整体涨幅为1.11%。其相关个股中，Cyclerion Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 涨幅较大，Cyclerion Therapeutics, Inc.、Nls Pharmaceutics Ltd.、Silexion Therapeutics Corp较为活跃，换手率分别为1894.57%、1872.70%、140.01%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cyclerion Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为63.20%、56.30%、52.24%。Mesoblast Ltd公司简介：Mesoblast Ltd是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013123441898776867&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013123441898776867&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MESO","BK4139"],"gpt_icon":0},{"id":"2507463193","title":"Mesoblast Ltd盘中异动 股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507463193","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507463193?lang=zh_cn&edition=full","pubTime":"2025-01-29 22:31","pubTimestamp":1738161060,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日22时31分，Mesoblast Ltd股票出现波动，股价快速上涨5.08%。截至发稿，该股报19.25美元/股，成交量1.3719万股，换手率0.01%，振幅0.05%。Mesoblast Ltd股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Ocean Biomedical Inc C/Wts 14/02/2028 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大，Silexion Therapeutics Corp、60 Degrees Pharmaceuticals, Inc.、Vincerx Pharma, Inc.较为活跃，换手率分别为1777.57%、1433.79%、606.92%，振幅较大的相关个股有60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Evaxion Biotech As、Onconetix, Inc.，振幅分别为50.00%、8.95%、7.82%。Mesoblast Ltd公司简介：Mesoblast Ltd是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129223101a23366bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129223101a23366bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MESO"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.mesoblast.com","stockEarnings":[{"period":"1week","weight":-0.1301},{"period":"1month","weight":-0.1588},{"period":"3month","weight":-0.1243},{"period":"6month","weight":0.1266},{"period":"1year","weight":-0.1539},{"period":"ytd","weight":-0.1957}],"compareEarnings":[{"period":"1week","weight":0.0058},{"period":"1month","weight":-0.0081},{"period":"3month","weight":0.0071},{"period":"6month","weight":0.0662},{"period":"1year","weight":0.1552},{"period":"ytd","weight":0.0065}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Mesoblast Limited于2004年6月8日在澳大利亚成立。该公司在开发同种异体细胞药物方面处于世界领先地位。该公司利用其专有的间充质谱系细胞治疗技术平台建立了广泛的商业产品和后期产品候选产品组合。","yearOnYearQuotes":[{"month":1,"riseRate":0.545455,"avgChangeRate":0.004747},{"month":2,"riseRate":0.454545,"avgChangeRate":0.029971},{"month":3,"riseRate":0.454545,"avgChangeRate":0.143169},{"month":4,"riseRate":0.4,"avgChangeRate":0.169294},{"month":5,"riseRate":0.5,"avgChangeRate":-0.027677},{"month":6,"riseRate":0.3,"avgChangeRate":-0.077641},{"month":7,"riseRate":0.6,"avgChangeRate":0.120859},{"month":8,"riseRate":0.2,"avgChangeRate":-0.055117},{"month":9,"riseRate":0.4,"avgChangeRate":0.04193},{"month":10,"riseRate":0.5,"avgChangeRate":-0.049086},{"month":11,"riseRate":0.8,"avgChangeRate":0.095285},{"month":12,"riseRate":0.545455,"avgChangeRate":0.005342}],"exchange":"NASDAQ","name":"Mesoblast Limited","nameEN":"Mesoblast"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Mesoblast Limited(MESO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Mesoblast Limited(MESO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Mesoblast Limited,MESO,Mesoblast Limited股票,Mesoblast Limited股票老虎,Mesoblast Limited股票老虎国际,Mesoblast Limited行情,Mesoblast Limited股票行情,Mesoblast Limited股价,Mesoblast Limited股市,Mesoblast Limited股票价格,Mesoblast Limited股票交易,Mesoblast Limited股票购买,Mesoblast Limited股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Mesoblast Limited(MESO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Mesoblast Limited(MESO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}